A growing body of research shows man’s best friend is speeding up the development of cancer-fighting drugs.

How man’s best friend might be the key to battling cancer

According to researchers, there are tumor types that develop in cats and dogs similar to those in humans

A new joint study by UC Davis, the University of Wisconsin and Colorado State University is looking for healthy canines to participate in a study that may benefit man and man's best friend alike.

According to Jenna Burton, Associate professor of clinical oncology at UC Davis, the Vaccination Against Canine Cancer Study began in May and currently has 30 dogs enrolled at the Davis site, with 190 total across the three universities. 

Burton said Davis is hoping for 275 pets to participate in the five-year study, which is being supported by the Open Philanthropy Project from Stefan Johnson of Arizona State University. 

"This is a study that is being conducted for a cancer preventive vaccine that has never been done before. We're not just focusing on one type of cancer, but to see if the immune system can be geared to prevent several types of cancer," Burton said. 

The study would aim to aid the immune system in recognizing abnormal proteins earlier. According to Burton, there are tumor types that develop in cats and dogs that are similar to those in humans. She says that the study is a two-way street, which could benefit canines and humans alike. Burton says that some studies estimate that as high as 50% of dogs over the age of 10 are diagnosed with cancer. 

"Just like humans, dogs are living longer and are developing cancer in greater numbers. Immunotherapy is an exploding field, and dogs can be very helpful in that regard," Burton said. "We can learn a lot from the amazing work being done and veterinary oncology can help a lot with that. Pets live in the same environment as us. They drink the same water and breathe the same air." 

Dogs involved in the study must meet a list of criteria and would undergo a number of screenings and examinations. Participating canines must be between 6 and 10 years old, of mixed breed, live within 150 miles of UC Davis, have had a veterinary visit within the past 12 months and have three years of previous medical history available, amongst other criteria. 

According to Burton, participants will be chosen at random to receive placebo vaccines. A financial incentive is offered to cover veterinary visits for dogs participating in the study. 

To find out if your dog is eligible, visit the UC Davis Veterinary Center for Clinical Trials website.

Support real journalism. Support local journalism. Subscribe to The Atlanta Journal-Constitution today. See offers.

Your subscription to the Atlanta Journal-Constitution funds in-depth reporting and investigations that keep you informed. Thank you for supporting real journalism.